// App-Quantinova.ai

N13 : Clinical service delivery implications of the Covid-19 pandemic on people with inflammatory bowel disease: a qualitative study

Researchers

Presenter

  • Kemp, K

Principal Investigators

  • Avery, P

  • Bryant, R

  • Cross, A

  • Danter, K

  • Kneebone, A

  • Morris, D

  • Walker, A

  • Whitley, L

  • Dibley, L

Medical Centers

  • Manchester Royal Infirmary, Gastroenterology, Manchester, United Kingdom

  • St Mark's Hospital- Harrow, IBD Unit, London, United Kingdom

  • Patient & Public Involvement Colleague, x, x, United Kingdom

  • Gloucestershire Hospitals NHS Foundation Trust, Gastroenterology, Gloucester, United Kingdom

  • Royal London Hospital, Gastroenterology, London, United Kingdom

  • Lister Hospital, Stevenage, United Kingdom

  • South Warwickshire NHS Foundation Trust, Gastroenterology, Warwick, United Kingdom

  • Kings College Hospital NHS Foundation Trust, Gastroenterology, London, United Kingdom

  • University of Greenwich, Faculty of Education- Health and Human Sciences, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Infectious Diseases (ID)

  • Gastroenterology (GU)

  • Genetic Disorder

Disease

  • Inflammatory bowel disease

  • Ulcerative colitis

  • Crohn's disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved